These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18782589)

  • 21. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation.
    Jangra RK; Yi M; Lemon SM
    J Virol; 2010 Jul; 84(13):6810-24. PubMed ID: 20392846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA.
    Ma J; Rong L; Zhou Y; Roy BB; Lu J; Abrahamyan L; Mouland AJ; Pan Q; Liang C
    Virology; 2008 May; 375(1):253-64. PubMed ID: 18289627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene knockdown by ecdysone-based inducible RNAi in stable mammalian cell lines.
    Rangasamy D; Tremethick DJ; Greaves IK
    Nat Protoc; 2008; 3(1):79-88. PubMed ID: 18193024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA helicase A interacts with RISC in human cells and functions in RISC loading.
    Robb GB; Rana TM
    Mol Cell; 2007 May; 26(4):523-37. PubMed ID: 17531811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).
    Dwivedi M; Misra SP; Misra V; Waikhom RK; Bhatnagar M
    Natl Med J India; 2008; 21(3):123-7. PubMed ID: 19004143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
    Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
    Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
    Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
    Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of small regulatory RNAs on the viral infection--new strategies in HCV therapy].
    Figlerowicz M; Tyczewska A; Figlerowicz M
    Przegl Epidemiol; 2006; 60(4):693-700. PubMed ID: 17682750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.
    Angus AG; Dalrymple D; Boulant S; McGivern DR; Clayton RF; Scott MJ; Adair R; Graham S; Owsianka AM; Targett-Adams P; Li K; Wakita T; McLauchlan J; Lemon SM; Patel AH
    J Gen Virol; 2010 Jan; 91(Pt 1):122-32. PubMed ID: 19793905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression.
    Suzuki H; Tamai N; Habu Y; Chang MO; Takaku H
    FEBS Lett; 2008 Sep; 582(20):3085-9. PubMed ID: 18692048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication.
    Vaillancourt FH; Pilote L; Cartier M; Lippens J; Liuzzi M; Bethell RC; Cordingley MG; Kukolj G
    Virology; 2009 Apr; 387(1):5-10. PubMed ID: 19304308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of nucleolar translocation of RNA helicase A.
    Liu Z; Kenworthy R; Green C; Tang H
    Exp Cell Res; 2007 Oct; 313(17):3743-54. PubMed ID: 17822697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C.
    Yokota T; Iijima S; Kubodera T; Ishii K; Katakai Y; Ageyama N; Chen Y; Lee YJ; Unno T; Nishina K; Iwasaki Y; Maki N; Mizusawa H; Akari H
    Biochem Biophys Res Commun; 2007 Sep; 361(2):294-300. PubMed ID: 17655825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.
    Wu Z; Gao Y; Sun L; Tien P; Jin Q
    Antiviral Res; 2008 Dec; 80(3):295-301. PubMed ID: 18662724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and application of a stable HeLa cell line capable of site-specific transgenesis using the Cre-lox system: establishment and application of a stable TNFRI knockdown cell line to cytotoxicity assay.
    Saito F; Yokota H; Sudo Y; Yakabe Y; Takeyama H; Matsunaga T
    Toxicol In Vitro; 2008 Jun; 22(4):1077-87. PubMed ID: 18356016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible RNA interference-mediated gene silencing using nanostructured gene delivery arrays.
    Mann DG; McKnight TE; McPherson JT; Hoyt PR; Melechko AV; Simpson ML; Sayler GS
    ACS Nano; 2008 Jan; 2(1):69-76. PubMed ID: 19206549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.